Global Gene Detection for Individualized Cancer Therapy Market Insights, Forecast to 2029
This report presents an overview of global market for Gene Detection for Individualized Cancer Therapy market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Gene Detection for Individualized Cancer Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gene Detection for Individualized Cancer Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gene Detection for Individualized Cancer Therapy revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Gene Detection for Individualized Cancer Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Gene Detection for Individualized Cancer Therapy revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Premed, Yin Feng Gene, United Gene Group, Geneis, Topgen, Annoroad, Gene+, Sanvalley and Sansure, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Gene Detection for Individualized Cancer Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Detection for Individualized Cancer Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Detection for Individualized Cancer Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Gene Detection for Individualized Cancer Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gene Detection for Individualized Cancer Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gene Detection for Individualized Cancer Therapy revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Gene Detection for Individualized Cancer Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Gene Detection for Individualized Cancer Therapy revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Premed, Yin Feng Gene, United Gene Group, Geneis, Topgen, Annoroad, Gene+, Sanvalley and Sansure, etc.
By Company
- Premed
- Yin Feng Gene
- United Gene Group
- Geneis
- Topgen
- Annoroad
- Gene+
- Sanvalley
- Sansure
- Genetic Screening
- Reproductive Genetic Testing
- Diagnostic Test
- Gene carrier Test
- Testing Before Symptoms Appear
- Hospital
- Clinic
- Diagnostic Center
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Gene Detection for Individualized Cancer Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Detection for Individualized Cancer Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Detection for Individualized Cancer Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Genetic Screening
1.2.3 Reproductive Genetic Testing
1.2.4 Diagnostic Test
1.2.5 Gene carrier Test
1.2.6 Testing Before Symptoms Appear
1.3 Market by Application
1.3.1 Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Diagnostic Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Gene Detection for Individualized Cancer Therapy Market Perspective (2018-2029)
2.2 Global Gene Detection for Individualized Cancer Therapy Growth Trends by Region
2.2.1 Gene Detection for Individualized Cancer Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Detection for Individualized Cancer Therapy Historic Market Size by Region (2018-2023)
2.2.3 Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Region (2024-2029)
2.3 Gene Detection for Individualized Cancer Therapy Market Dynamics
2.3.1 Gene Detection for Individualized Cancer Therapy Industry Trends
2.3.2 Gene Detection for Individualized Cancer Therapy Market Drivers
2.3.3 Gene Detection for Individualized Cancer Therapy Market Challenges
2.3.4 Gene Detection for Individualized Cancer Therapy Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Gene Detection for Individualized Cancer Therapy by Players
3.1.1 Global Gene Detection for Individualized Cancer Therapy Revenue by Players (2018-2023)
3.1.2 Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Gene Detection for Individualized Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gene Detection for Individualized Cancer Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Gene Detection for Individualized Cancer Therapy Market Concentration Ratio
3.4.1 Global Gene Detection for Individualized Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Detection for Individualized Cancer Therapy Revenue in 2022
3.5 Global Key Players of Gene Detection for Individualized Cancer Therapy Head office and Area Served
3.6 Global Key Players of Gene Detection for Individualized Cancer Therapy, Product and Application
3.7 Global Key Players of Gene Detection for Individualized Cancer Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 GENE DETECTION FOR INDIVIDUALIZED CANCER THERAPY BREAKDOWN DATA BY TYPE
4.1 Global Gene Detection for Individualized Cancer Therapy Historic Market Size by Type (2018-2023)
4.2 Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Type (2024-2029)
5 GENE DETECTION FOR INDIVIDUALIZED CANCER THERAPY BREAKDOWN DATA BY APPLICATION
5.1 Global Gene Detection for Individualized Cancer Therapy Historic Market Size by Application (2018-2023)
5.2 Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Gene Detection for Individualized Cancer Therapy Market Size (2018-2029)
6.2 North America Gene Detection for Individualized Cancer Therapy Market Size by Type
6.2.1 North America Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023)
6.2.2 North America Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029)
6.2.3 North America Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
6.3 North America Gene Detection for Individualized Cancer Therapy Market Size by Application
6.3.1 North America Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023)
6.3.2 North America Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029)
6.3.3 North America Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
6.4 North America Gene Detection for Individualized Cancer Therapy Market Size by Country
6.4.1 North America Gene Detection for Individualized Cancer Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2018-2023)
6.4.3 North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Gene Detection for Individualized Cancer Therapy Market Size (2018-2029)
7.2 Europe Gene Detection for Individualized Cancer Therapy Market Size by Type
7.2.1 Europe Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023)
7.2.2 Europe Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029)
7.2.3 Europe Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
7.3 Europe Gene Detection for Individualized Cancer Therapy Market Size by Application
7.3.1 Europe Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023)
7.3.2 Europe Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029)
7.3.3 Europe Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
7.4 Europe Gene Detection for Individualized Cancer Therapy Market Size by Country
7.4.1 Europe Gene Detection for Individualized Cancer Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2018-2023)
7.4.3 Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Gene Detection for Individualized Cancer Therapy Market Size (2018-2029)
8.2 China Gene Detection for Individualized Cancer Therapy Market Size by Type
8.2.1 China Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023)
8.2.2 China Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029)
8.2.3 China Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
8.3 China Gene Detection for Individualized Cancer Therapy Market Size by Application
8.3.1 China Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023)
8.3.2 China Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029)
8.3.3 China Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Gene Detection for Individualized Cancer Therapy Market Size (2018-2029)
9.2 Asia Gene Detection for Individualized Cancer Therapy Market Size by Type
9.2.1 Asia Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023)
9.2.2 Asia Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029)
9.2.3 Asia Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
9.3 Asia Gene Detection for Individualized Cancer Therapy Market Size by Application
9.3.1 Asia Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023)
9.3.2 Asia Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029)
9.3.3 Asia Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
9.4 Asia Gene Detection for Individualized Cancer Therapy Market Size by Region
9.4.1 Asia Gene Detection for Individualized Cancer Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Gene Detection for Individualized Cancer Therapy Market Size by Region (2018-2023)
9.4.3 Asia Gene Detection for Individualized Cancer Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Premed
11.1.1 Premed Company Details
11.1.2 Premed Business Overview
11.1.3 Premed Gene Detection for Individualized Cancer Therapy Introduction
11.1.4 Premed Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.1.5 Premed Recent Developments
11.2 Yin Feng Gene
11.2.1 Yin Feng Gene Company Details
11.2.2 Yin Feng Gene Business Overview
11.2.3 Yin Feng Gene Gene Detection for Individualized Cancer Therapy Introduction
11.2.4 Yin Feng Gene Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.2.5 Yin Feng Gene Recent Developments
11.3 United Gene Group
11.3.1 United Gene Group Company Details
11.3.2 United Gene Group Business Overview
11.3.3 United Gene Group Gene Detection for Individualized Cancer Therapy Introduction
11.3.4 United Gene Group Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.3.5 United Gene Group Recent Developments
11.4 Geneis
11.4.1 Geneis Company Details
11.4.2 Geneis Business Overview
11.4.3 Geneis Gene Detection for Individualized Cancer Therapy Introduction
11.4.4 Geneis Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.4.5 Geneis Recent Developments
11.5 Topgen
11.5.1 Topgen Company Details
11.5.2 Topgen Business Overview
11.5.3 Topgen Gene Detection for Individualized Cancer Therapy Introduction
11.5.4 Topgen Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.5.5 Topgen Recent Developments
11.6 Annoroad
11.6.1 Annoroad Company Details
11.6.2 Annoroad Business Overview
11.6.3 Annoroad Gene Detection for Individualized Cancer Therapy Introduction
11.6.4 Annoroad Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.6.5 Annoroad Recent Developments
11.7 Gene+
11.7.1 Gene+ Company Details
11.7.2 Gene+ Business Overview
11.7.3 Gene+ Gene Detection for Individualized Cancer Therapy Introduction
11.7.4 Gene+ Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.7.5 Gene+ Recent Developments
11.8 Sanvalley
11.8.1 Sanvalley Company Details
11.8.2 Sanvalley Business Overview
11.8.3 Sanvalley Gene Detection for Individualized Cancer Therapy Introduction
11.8.4 Sanvalley Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.8.5 Sanvalley Recent Developments
11.9 Sansure
11.9.1 Sansure Company Details
11.9.2 Sansure Business Overview
11.9.3 Sansure Gene Detection for Individualized Cancer Therapy Introduction
11.9.4 Sansure Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.9.5 Sansure Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Genetic Screening
1.2.3 Reproductive Genetic Testing
1.2.4 Diagnostic Test
1.2.5 Gene carrier Test
1.2.6 Testing Before Symptoms Appear
1.3 Market by Application
1.3.1 Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Diagnostic Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Gene Detection for Individualized Cancer Therapy Market Perspective (2018-2029)
2.2 Global Gene Detection for Individualized Cancer Therapy Growth Trends by Region
2.2.1 Gene Detection for Individualized Cancer Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Detection for Individualized Cancer Therapy Historic Market Size by Region (2018-2023)
2.2.3 Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Region (2024-2029)
2.3 Gene Detection for Individualized Cancer Therapy Market Dynamics
2.3.1 Gene Detection for Individualized Cancer Therapy Industry Trends
2.3.2 Gene Detection for Individualized Cancer Therapy Market Drivers
2.3.3 Gene Detection for Individualized Cancer Therapy Market Challenges
2.3.4 Gene Detection for Individualized Cancer Therapy Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Gene Detection for Individualized Cancer Therapy by Players
3.1.1 Global Gene Detection for Individualized Cancer Therapy Revenue by Players (2018-2023)
3.1.2 Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Gene Detection for Individualized Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gene Detection for Individualized Cancer Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Gene Detection for Individualized Cancer Therapy Market Concentration Ratio
3.4.1 Global Gene Detection for Individualized Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Detection for Individualized Cancer Therapy Revenue in 2022
3.5 Global Key Players of Gene Detection for Individualized Cancer Therapy Head office and Area Served
3.6 Global Key Players of Gene Detection for Individualized Cancer Therapy, Product and Application
3.7 Global Key Players of Gene Detection for Individualized Cancer Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 GENE DETECTION FOR INDIVIDUALIZED CANCER THERAPY BREAKDOWN DATA BY TYPE
4.1 Global Gene Detection for Individualized Cancer Therapy Historic Market Size by Type (2018-2023)
4.2 Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Type (2024-2029)
5 GENE DETECTION FOR INDIVIDUALIZED CANCER THERAPY BREAKDOWN DATA BY APPLICATION
5.1 Global Gene Detection for Individualized Cancer Therapy Historic Market Size by Application (2018-2023)
5.2 Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Gene Detection for Individualized Cancer Therapy Market Size (2018-2029)
6.2 North America Gene Detection for Individualized Cancer Therapy Market Size by Type
6.2.1 North America Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023)
6.2.2 North America Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029)
6.2.3 North America Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
6.3 North America Gene Detection for Individualized Cancer Therapy Market Size by Application
6.3.1 North America Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023)
6.3.2 North America Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029)
6.3.3 North America Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
6.4 North America Gene Detection for Individualized Cancer Therapy Market Size by Country
6.4.1 North America Gene Detection for Individualized Cancer Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2018-2023)
6.4.3 North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Gene Detection for Individualized Cancer Therapy Market Size (2018-2029)
7.2 Europe Gene Detection for Individualized Cancer Therapy Market Size by Type
7.2.1 Europe Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023)
7.2.2 Europe Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029)
7.2.3 Europe Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
7.3 Europe Gene Detection for Individualized Cancer Therapy Market Size by Application
7.3.1 Europe Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023)
7.3.2 Europe Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029)
7.3.3 Europe Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
7.4 Europe Gene Detection for Individualized Cancer Therapy Market Size by Country
7.4.1 Europe Gene Detection for Individualized Cancer Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2018-2023)
7.4.3 Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Gene Detection for Individualized Cancer Therapy Market Size (2018-2029)
8.2 China Gene Detection for Individualized Cancer Therapy Market Size by Type
8.2.1 China Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023)
8.2.2 China Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029)
8.2.3 China Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
8.3 China Gene Detection for Individualized Cancer Therapy Market Size by Application
8.3.1 China Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023)
8.3.2 China Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029)
8.3.3 China Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Gene Detection for Individualized Cancer Therapy Market Size (2018-2029)
9.2 Asia Gene Detection for Individualized Cancer Therapy Market Size by Type
9.2.1 Asia Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023)
9.2.2 Asia Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029)
9.2.3 Asia Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
9.3 Asia Gene Detection for Individualized Cancer Therapy Market Size by Application
9.3.1 Asia Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023)
9.3.2 Asia Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029)
9.3.3 Asia Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
9.4 Asia Gene Detection for Individualized Cancer Therapy Market Size by Region
9.4.1 Asia Gene Detection for Individualized Cancer Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Gene Detection for Individualized Cancer Therapy Market Size by Region (2018-2023)
9.4.3 Asia Gene Detection for Individualized Cancer Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Premed
11.1.1 Premed Company Details
11.1.2 Premed Business Overview
11.1.3 Premed Gene Detection for Individualized Cancer Therapy Introduction
11.1.4 Premed Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.1.5 Premed Recent Developments
11.2 Yin Feng Gene
11.2.1 Yin Feng Gene Company Details
11.2.2 Yin Feng Gene Business Overview
11.2.3 Yin Feng Gene Gene Detection for Individualized Cancer Therapy Introduction
11.2.4 Yin Feng Gene Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.2.5 Yin Feng Gene Recent Developments
11.3 United Gene Group
11.3.1 United Gene Group Company Details
11.3.2 United Gene Group Business Overview
11.3.3 United Gene Group Gene Detection for Individualized Cancer Therapy Introduction
11.3.4 United Gene Group Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.3.5 United Gene Group Recent Developments
11.4 Geneis
11.4.1 Geneis Company Details
11.4.2 Geneis Business Overview
11.4.3 Geneis Gene Detection for Individualized Cancer Therapy Introduction
11.4.4 Geneis Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.4.5 Geneis Recent Developments
11.5 Topgen
11.5.1 Topgen Company Details
11.5.2 Topgen Business Overview
11.5.3 Topgen Gene Detection for Individualized Cancer Therapy Introduction
11.5.4 Topgen Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.5.5 Topgen Recent Developments
11.6 Annoroad
11.6.1 Annoroad Company Details
11.6.2 Annoroad Business Overview
11.6.3 Annoroad Gene Detection for Individualized Cancer Therapy Introduction
11.6.4 Annoroad Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.6.5 Annoroad Recent Developments
11.7 Gene+
11.7.1 Gene+ Company Details
11.7.2 Gene+ Business Overview
11.7.3 Gene+ Gene Detection for Individualized Cancer Therapy Introduction
11.7.4 Gene+ Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.7.5 Gene+ Recent Developments
11.8 Sanvalley
11.8.1 Sanvalley Company Details
11.8.2 Sanvalley Business Overview
11.8.3 Sanvalley Gene Detection for Individualized Cancer Therapy Introduction
11.8.4 Sanvalley Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.8.5 Sanvalley Recent Developments
11.9 Sansure
11.9.1 Sansure Company Details
11.9.2 Sansure Business Overview
11.9.3 Sansure Gene Detection for Individualized Cancer Therapy Introduction
11.9.4 Sansure Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
11.9.5 Sansure Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Genetic Screening
Table 3. Key Players of Reproductive Genetic Testing
Table 4. Key Players of Diagnostic Test
Table 5. Key Players of Gene carrier Test
Table 6. Key Players of Testing Before Symptoms Appear
Table 7. Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Gene Detection for Individualized Cancer Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Gene Detection for Individualized Cancer Therapy Market Share by Region (2018-2023)
Table 11. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Gene Detection for Individualized Cancer Therapy Market Share by Region (2024-2029)
Table 13. Gene Detection for Individualized Cancer Therapy Market Trends
Table 14. Gene Detection for Individualized Cancer Therapy Market Drivers
Table 15. Gene Detection for Individualized Cancer Therapy Market Challenges
Table 16. Gene Detection for Individualized Cancer Therapy Market Restraints
Table 17. Global Gene Detection for Individualized Cancer Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Gene Detection for Individualized Cancer Therapy Revenue Share by Players (2018-2023)
Table 19. Global Top Gene Detection for Individualized Cancer Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Detection for Individualized Cancer Therapy as of 2022)
Table 20. Global Gene Detection for Individualized Cancer Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Gene Detection for Individualized Cancer Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Gene Detection for Individualized Cancer Therapy, Headquarters and Area Served
Table 23. Global Key Players of Gene Detection for Individualized Cancer Therapy, Product and Application
Table 24. Global Key Players of Gene Detection for Individualized Cancer Therapy, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Type (2018-2023)
Table 28. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Type (2024-2029)
Table 30. Global Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Gene Detection for Individualized Cancer Therapy Revenue Share by Application (2018-2023)
Table 32. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Gene Detection for Individualized Cancer Therapy Revenue Share by Application (2024-2029)
Table 34. North America Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Gene Detection for Individualized Cancer Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Gene Detection for Individualized Cancer Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Gene Detection for Individualized Cancer Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Gene Detection for Individualized Cancer Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Gene Detection for Individualized Cancer Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 66. Premed Company Details
Table 67. Premed Business Overview
Table 68. Premed Gene Detection for Individualized Cancer Therapy Product
Table 69. Premed Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 70. Premed Recent Developments
Table 71. Yin Feng Gene Company Details
Table 72. Yin Feng Gene Business Overview
Table 73. Yin Feng Gene Gene Detection for Individualized Cancer Therapy Product
Table 74. Yin Feng Gene Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 75. Yin Feng Gene Recent Developments
Table 76. United Gene Group Company Details
Table 77. United Gene Group Business Overview
Table 78. United Gene Group Gene Detection for Individualized Cancer Therapy Product
Table 79. United Gene Group Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 80. United Gene Group Recent Developments
Table 81. Geneis Company Details
Table 82. Geneis Business Overview
Table 83. Geneis Gene Detection for Individualized Cancer Therapy Product
Table 84. Geneis Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 85. Geneis Recent Developments
Table 86. Topgen Company Details
Table 87. Topgen Business Overview
Table 88. Topgen Gene Detection for Individualized Cancer Therapy Product
Table 89. Topgen Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 90. Topgen Recent Developments
Table 91. Annoroad Company Details
Table 92. Annoroad Business Overview
Table 93. Annoroad Gene Detection for Individualized Cancer Therapy Product
Table 94. Annoroad Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 95. Annoroad Recent Developments
Table 96. Gene+ Company Details
Table 97. Gene+ Business Overview
Table 98. Gene+ Gene Detection for Individualized Cancer Therapy Product
Table 99. Gene+ Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 100. Gene+ Recent Developments
Table 101. Sanvalley Company Details
Table 102. Sanvalley Business Overview
Table 103. Sanvalley Gene Detection for Individualized Cancer Therapy Product
Table 104. Sanvalley Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 105. Sanvalley Recent Developments
Table 106. Sansure Company Details
Table 107. Sansure Business Overview
Table 108. Sansure Gene Detection for Individualized Cancer Therapy Product
Table 109. Sansure Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 110. Sansure Recent Developments
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 1. Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Genetic Screening
Table 3. Key Players of Reproductive Genetic Testing
Table 4. Key Players of Diagnostic Test
Table 5. Key Players of Gene carrier Test
Table 6. Key Players of Testing Before Symptoms Appear
Table 7. Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Gene Detection for Individualized Cancer Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Gene Detection for Individualized Cancer Therapy Market Share by Region (2018-2023)
Table 11. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Gene Detection for Individualized Cancer Therapy Market Share by Region (2024-2029)
Table 13. Gene Detection for Individualized Cancer Therapy Market Trends
Table 14. Gene Detection for Individualized Cancer Therapy Market Drivers
Table 15. Gene Detection for Individualized Cancer Therapy Market Challenges
Table 16. Gene Detection for Individualized Cancer Therapy Market Restraints
Table 17. Global Gene Detection for Individualized Cancer Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Gene Detection for Individualized Cancer Therapy Revenue Share by Players (2018-2023)
Table 19. Global Top Gene Detection for Individualized Cancer Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Detection for Individualized Cancer Therapy as of 2022)
Table 20. Global Gene Detection for Individualized Cancer Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Gene Detection for Individualized Cancer Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Gene Detection for Individualized Cancer Therapy, Headquarters and Area Served
Table 23. Global Key Players of Gene Detection for Individualized Cancer Therapy, Product and Application
Table 24. Global Key Players of Gene Detection for Individualized Cancer Therapy, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Type (2018-2023)
Table 28. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Type (2024-2029)
Table 30. Global Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Gene Detection for Individualized Cancer Therapy Revenue Share by Application (2018-2023)
Table 32. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Gene Detection for Individualized Cancer Therapy Revenue Share by Application (2024-2029)
Table 34. North America Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Gene Detection for Individualized Cancer Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Gene Detection for Individualized Cancer Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Gene Detection for Individualized Cancer Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Gene Detection for Individualized Cancer Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Gene Detection for Individualized Cancer Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 66. Premed Company Details
Table 67. Premed Business Overview
Table 68. Premed Gene Detection for Individualized Cancer Therapy Product
Table 69. Premed Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 70. Premed Recent Developments
Table 71. Yin Feng Gene Company Details
Table 72. Yin Feng Gene Business Overview
Table 73. Yin Feng Gene Gene Detection for Individualized Cancer Therapy Product
Table 74. Yin Feng Gene Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 75. Yin Feng Gene Recent Developments
Table 76. United Gene Group Company Details
Table 77. United Gene Group Business Overview
Table 78. United Gene Group Gene Detection for Individualized Cancer Therapy Product
Table 79. United Gene Group Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 80. United Gene Group Recent Developments
Table 81. Geneis Company Details
Table 82. Geneis Business Overview
Table 83. Geneis Gene Detection for Individualized Cancer Therapy Product
Table 84. Geneis Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 85. Geneis Recent Developments
Table 86. Topgen Company Details
Table 87. Topgen Business Overview
Table 88. Topgen Gene Detection for Individualized Cancer Therapy Product
Table 89. Topgen Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 90. Topgen Recent Developments
Table 91. Annoroad Company Details
Table 92. Annoroad Business Overview
Table 93. Annoroad Gene Detection for Individualized Cancer Therapy Product
Table 94. Annoroad Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 95. Annoroad Recent Developments
Table 96. Gene+ Company Details
Table 97. Gene+ Business Overview
Table 98. Gene+ Gene Detection for Individualized Cancer Therapy Product
Table 99. Gene+ Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 100. Gene+ Recent Developments
Table 101. Sanvalley Company Details
Table 102. Sanvalley Business Overview
Table 103. Sanvalley Gene Detection for Individualized Cancer Therapy Product
Table 104. Sanvalley Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 105. Sanvalley Recent Developments
Table 106. Sansure Company Details
Table 107. Sansure Business Overview
Table 108. Sansure Gene Detection for Individualized Cancer Therapy Product
Table 109. Sansure Revenue in Gene Detection for Individualized Cancer Therapy Business (2018-2023) & (US$ Million)
Table 110. Sansure Recent Developments
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Gene Detection for Individualized Cancer Therapy Market Share by Type: 2022 VS 2029
Figure 3. Genetic Screening Features
Figure 4. Reproductive Genetic Testing Features
Figure 5. Diagnostic Test Features
Figure 6. Gene carrier Test Features
Figure 7. Testing Before Symptoms Appear Features
Figure 8. Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Gene Detection for Individualized Cancer Therapy Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Diagnostic Center Case Studies
Figure 13. Gene Detection for Individualized Cancer Therapy Report Years Considered
Figure 14. Global Gene Detection for Individualized Cancer Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Gene Detection for Individualized Cancer Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Gene Detection for Individualized Cancer Therapy Market Share by Region: 2022 VS 2029
Figure 17. Global Gene Detection for Individualized Cancer Therapy Market Share by Players in 2022
Figure 18. Global Top Gene Detection for Individualized Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Detection for Individualized Cancer Therapy as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Gene Detection for Individualized Cancer Therapy Revenue in 2022
Figure 20. North America Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
Figure 22. North America Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
Figure 23. North America Gene Detection for Individualized Cancer Therapy Market Share by Country (2018-2029)
Figure 24. United States Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Gene Detection for Individualized Cancer Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
Figure 28. Europe Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
Figure 29. Europe Gene Detection for Individualized Cancer Therapy Market Share by Country (2018-2029)
Figure 30. Germany Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Gene Detection for Individualized Cancer Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
Figure 38. China Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
Figure 39. Asia Gene Detection for Individualized Cancer Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
Figure 41. Asia Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
Figure 42. Asia Gene Detection for Individualized Cancer Therapy Market Share by Region (2018-2029)
Figure 43. Japan Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Share by Country (2018-2029)
Figure 53. Brazil Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Premed Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 60. Yin Feng Gene Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 61. United Gene Group Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 62. Geneis Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 63. Topgen Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 64. Annoroad Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 65. Gene+ Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 66. Sanvalley Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 67. Sansure Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Figure 1. Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Gene Detection for Individualized Cancer Therapy Market Share by Type: 2022 VS 2029
Figure 3. Genetic Screening Features
Figure 4. Reproductive Genetic Testing Features
Figure 5. Diagnostic Test Features
Figure 6. Gene carrier Test Features
Figure 7. Testing Before Symptoms Appear Features
Figure 8. Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Gene Detection for Individualized Cancer Therapy Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Diagnostic Center Case Studies
Figure 13. Gene Detection for Individualized Cancer Therapy Report Years Considered
Figure 14. Global Gene Detection for Individualized Cancer Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Gene Detection for Individualized Cancer Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Gene Detection for Individualized Cancer Therapy Market Share by Region: 2022 VS 2029
Figure 17. Global Gene Detection for Individualized Cancer Therapy Market Share by Players in 2022
Figure 18. Global Top Gene Detection for Individualized Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Detection for Individualized Cancer Therapy as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Gene Detection for Individualized Cancer Therapy Revenue in 2022
Figure 20. North America Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
Figure 22. North America Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
Figure 23. North America Gene Detection for Individualized Cancer Therapy Market Share by Country (2018-2029)
Figure 24. United States Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Gene Detection for Individualized Cancer Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
Figure 28. Europe Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
Figure 29. Europe Gene Detection for Individualized Cancer Therapy Market Share by Country (2018-2029)
Figure 30. Germany Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Gene Detection for Individualized Cancer Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
Figure 38. China Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
Figure 39. Asia Gene Detection for Individualized Cancer Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
Figure 41. Asia Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
Figure 42. Asia Gene Detection for Individualized Cancer Therapy Market Share by Region (2018-2029)
Figure 43. Japan Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Gene Detection for Individualized Cancer Therapy Market Share by Country (2018-2029)
Figure 53. Brazil Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Premed Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 60. Yin Feng Gene Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 61. United Gene Group Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 62. Geneis Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 63. Topgen Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 64. Annoroad Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 65. Gene+ Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 66. Sanvalley Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 67. Sansure Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
